首页 News 正文

Boston Science announces agreement to acquire medical technology company Axonics for $71 per share

芊芊551
266 0 0

On January 10th, Boston Scientific announced that it had recently signed the final agreement for the acquisition of Axonics, Inc. The acquisition price is $71 per share, traded in cash, with an equity value of approximately $3.7 billion and a corporate value of approximately $3.4 billion. Axonics is a publicly listed medical technology company primarily dedicated to developing and selling new products for the treatment of bladder and intestinal dysfunction.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

芊芊551 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    44